Retatrutide 30mg

A protocol running several months on 10mg vials will consume three or four lots before it finishes. Each boundary is a new certificate, a new set of analytical assumptions, and a confound that has to be either designed around or disclosed. Thirty milligrams from one synthesis removes that entirely: one lot number, one certificate, one set of assumptions for the duration.

This page is the 30mg vial specifically — for a discrete experiment see the Retatrutide 10mg vial, our standard listing, and for an extended single-arm protocol the Retatrutide 20mg.

The fill suits work where consistency across conditions matters more than the size of any single experiment:

The larger fill changes the arithmetic rather than the method.

These are solvent volumes for putting powder into solution.

They are not doses, and we publish no retatrutide dose in any fill — the compound holds no licence anywhere, so no established dose exists.

Nothing about the compound changes across our three fills. Same synthesis route, same ≥98% HPLC-UV purity specification, same mass-spectrometry identity check, same independent laboratories. What changes is the fill weight, the cost per milligram, how long one lot number lasts — and, for this fill at present, whether the certificate has been published here yet, which the section below sets out in full.

Anyone cross-referencing results between our 10mg, 20mg and 30mg vials is comparing the same material at different scales.

The 10mg and 20mg vials each have a signed third-party certificate published on their product page and indexed on our lab reports page. The 30mg lot is a newer fill and its certificate is not yet published here. Email us with your order ID and we will send the lot-matched documentation we hold for it.

We would rather say that plainly than show a download that does not exist — every certificate we publish is the unedited document for the exact lot dispatched. One thing worth knowing whichever fill you order: retatrutide has no resolvable PubChem record, the CID widely circulated for it returns tirzepatide, and the mass usually quoted for it is reported rather than verified.

Verify against the mass a certificate itself states, by mass spectrometry, rather than against a figure copied from a catalogue.

The 30mg fill is £124.99, which is £4.17 per milligram — the lowest per-milligram figure of the three we list, against £4.50 on the 20mg (£89.99) and £5.00 on the 10mg (£49.99). That is arithmetic from three prices published on this site, not a claim about the wider market, which no supplier can verify.

It matters most on exactly the long protocols this fill is intended for, where the alternative is buying the same quantity across three or four lots. All prices are per vial. There is no monthly or course price for any fill, because there is no schedule: this is lyophilised powder a researcher reconstitutes, and the vial and the milligram are the only units that honestly describe it.

The price in the buy panel is the authoritative current figure if this section ever falls behind it.

Orders placed before 6pm GMT on a working day leave Manchester the same day by Royal Mail Tracked 24. No overseas customs step, no anonymous fulfilment, and a registered UK address behind the sale. Lyophilised retatrutide is stable in transit — it travels far better than a solution — but it should go to -20°C on arrival rather than sit at room temperature.

Cold storage matters most once the vial is reconstituted, which is why the 28-day refrigerated window is stated on this page rather than buried in a policy.